SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-038526
Filing Date
2023-10-27
Accepted
2023-10-27 16:15:58
Documents
54
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1777126
2 CLAWBACK POLICY ex10-42.htm EX-10.42 70010
3 ex31-1.htm EX-31.1 13276
4 ex31-2.htm EX-31.2 13086
5 ex32-1.htm EX-32.1 8642
6 ex32-2.htm EX-32.2 8389
7 form10-q_001.jpg GRAPHIC 14080
  Complete submission text file 0001493152-23-038526.txt   5946638

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE mgrx-20230930.xsd EX-101.SCH 32043
9 XBRL CALCULATION FILE mgrx-20230930_cal.xml EX-101.CAL 39038
10 XBRL DEFINITION FILE mgrx-20230930_def.xml EX-101.DEF 153048
11 XBRL LABEL FILE mgrx-20230930_lab.xml EX-101.LAB 309156
12 XBRL PRESENTATION FILE mgrx-20230930_pre.xml EX-101.PRE 232057
48 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 605534
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

IRS No.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41615 | Film No.: 231355724
SIC: 8090 Services-Misc Health & Allied Services, NEC